NERVE TONIC
NDC 54973-3014, calcium phosphate, iron, potassium phosphate, unspecified form, magnesium phosphate, dibasic trihydrate, and sodium phosphate, tablet, from Hyland's Inc..
- Product NDC
- 54973-3014
- Status
- Listed
- Labeler
- Hyland's Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54973-3014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CALCIUM PHOSPHATE, UNSPECIFIED FORM3 [hp_X]/1
- IRON3 [hp_X]/1
- POTASSIUM PHOSPHATE, UNSPECIFIED FORM3 [hp_X]/1
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE3 [hp_X]/1
- SODIUM PHOSPHATE3 [hp_X]/1
Pharmacologic classes
Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54973-3014-2 | 54973301402 | 1 BOTTLE, PLASTIC in 1 CARTON (54973-3014-2) / 100 TABLET in 1 BOTTLE, PLASTIC |
| 54973-3014-3 | 54973301403 | 4 TABLET in 1 POUCH (54973-3014-3) |
| 54973-3014-4 | 54973301404 | 50 TABLET in 1 BOTTLE, PLASTIC (54973-3014-4) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 54973-3014 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54973-3014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54973-3014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.